BGP-15: A potential therapeutic agent for critical illness myopathy

Acta Physiol (Oxf). 2020 May;229(1):e13441. doi: 10.1111/apha.13441. Epub 2020 Jan 20.

Author

Takashi Yamada¹

Affiliation

¹ School of Health Sciences, Sapporo Medical University, Sapporo, Japan.

PMID: 31925993
DOI: 10.1111/apha.13441

No abstract available

Publication types

Editorial
Comment

MeSH terms

Animals
Critical Illness*
Intensive Care Units
Muscle, Skeletal
Muscular Diseases*
Oximes
Piperidines
Rats

Substances

Oximes
Piperidines
BGP 15